SCHEMBL17057475

SCHEMBL17057475

C=C1OCc2c(cc3n(c2=O)Cc2c-3nc3cc4c(cc3c2CN2CCN(C)CC2)OCCO4)C1(O)CC

nearest known ligand 0.86

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 19/20 0.86
SLC2A1 P11166 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25932537 1.00 TOP1 (0.86) TOP1SLC2A1
Lurtotecan SCHEMBL13992 0.92 TOP1 (1.00) TOP1SLC2A1
Lurtotecan SCHEMBL19208 0.92 TOP1 (1.00) TOP1SLC2A1
Lurtotecan SCHEMBL29774186 0.92 TOP1 (1.00) TOP1SLC2A1
Lurtotecan SCHEMBL29379042 0.92 TOP1 (0.98) TOP1SLC2A1
Lurtotecan SCHEMBL1649335 0.92 TOP1 (0.98) TOP1SLC2A1
Lurtotecan SCHEMBL1649336 0.91 TOP1 (0.97) TOP1SLC2A1
SCHEMBL13928539 0.89 TOP1 (0.82) TOP1SLC2A1
SCHEMBL26843277 0.89 TOP1 (0.82) TOP1SLC2A1
SCHEMBL31312371 0.88 TOP1 (1.00) TOP1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015128837-A1 METHODS OF TREATING CANCER PATIENTS RESPONDING TO EZH2 INHIBITOR GSK126 GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-09-03 WO disclosed